Live: Will Applied Materials Crush Tonight’s Q3 Earnings After 200% Rally?

Investing

Novo Nordisk : NVO

All Novo Nordisk Articles

175 Articles

Joel South | Jun 13, 2026 at 9:30 AM EDT

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care…

Vandita Jadeja | Jun 11, 2026 at 2:58 PM EDT

Eli Lilly vs Novo Nordisk: The Battle for Obesity Drug Supremacy

Eli Lilly (NYSE: LLY | LLY Price Prediction) and Novo Nordisk (NYSE: NVO) reported Q1 2026 results that pulled the…

Jeremy Phillips | Jun 11, 2026 at 9:30 AM EDT

The GLP-1 stock nobody is pricing in isn’t a drugmaker

Scott Galloway and Ed Elson laid out the math on Prof G Markets and it should make every fast food…

Gerelyn Terzo | Jun 3, 2026 at 9:03 AM EDT

Live Nasdaq Composite: Markets Take a Breather amid Stellar AI Earnings Cycle

This article will be updated throughout the day, so check back often for more daily updates. The markets are cradling…

Jeremy Phillips | Jun 3, 2026 at 8:38 AM EDT

5 Stocks Set to Cash in on The Next 90-Million Customer Industry. (It’s Not AI)

Wells Fargo’s chief agriculture economist Dr. Michael Swanson told Bloomberg Businessweek on May 29 that GLP-1 weight-loss drugs (Ozempic, Wegovy,…

Trey Thoelcke | May 26, 2026 at 8:50 AM EDT

If Viking Therapeutics Is Acquired, Here’s Who Wins

Polymarket traders are watching one biotech more closely than any other for an acquisition. Viking Therapeutics (NASDAQ: VKTX | VKTX…

Vandita Jadeja | May 21, 2026 at 8:25 AM EDT

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

Eli Lilly (NYSE:LLY | LLY Price Prediction) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5%…

Alex Sirois | May 18, 2026 at 1:55 PM EDT

Three Biotechs That Are Top Takeover Targets

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious:…

David Moadel | May 5, 2026 at 10:44 AM EDT

Barclays Hikes Eli Lilly Price Target to $1,400: Tirzepatide Momentum Steals the Show

Eli Lilly (NYSE:LLY | LLY Price Prediction) received another bullish call from Wall Street. Barclays analyst Emily Field raised her…

Thomas Richmond | Apr 30, 2026 at 8:05 PM EDT

Fast Money Panel Says Novo Nordisk Now More Compelling Than Eli Lilly After Falling 70%

CNBC’s Fast Money panel recently made a notable pivot on its April 24 episode, arguing that Novo Nordisk (NYSE:NVO |…

David Moadel | Apr 24, 2026 at 12:01 PM EDT

JPMorgan Initiates Hims & Hers With Overweight: Could the Novo Nordisk Deal Be the Turning Point?

Hims & Hers Health (NYSE:HIMS) just picked up a high-profile endorsement. JPMorgan analyst Cory Carpenter initiated coverage with an Overweight…

Ian Cooper | Apr 22, 2026 at 12:24 PM EDT

Biotech Investor Alex Karnal: GLP-1 Drugs Signal ‘Trillion-Dollar Revolution’ in Public Health

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech companies…

David Moadel | Apr 20, 2026 at 10:40 AM EDT

Hims & Hers Rallies 9% as Investors Bet Big on Peptide Pipeline and Novo Nordisk Deal

Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change…

Gerelyn Terzo | Apr 14, 2026 at 10:19 AM EDT

Live Nasdaq Composite: Markets Extend Rebound, Oil Slips in Pivot Toward Tech Deals

This article will be updated throughout the day, so check back often for more daily updates. Markets are continuing to…

Vandita Jadeja | Apr 10, 2026 at 12:09 PM EDT

Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader

Eli Lilly and Company (NYSE:LLY | LLY Price Prediction) and Novo Nordisk A/S (NYSE:NVO) reported quarterly results in early February,…

1 2 3 4 … 12

Novo Nordisk : NVO

All Novo Nordisk Articles

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Eli Lilly vs Novo Nordisk: The Battle for Obesity Drug Supremacy

The GLP-1 stock nobody is pricing in isn’t a drugmaker

Live Nasdaq Composite: Markets Take a Breather amid Stellar AI Earnings Cycle

5 Stocks Set to Cash in on The Next 90-Million Customer Industry. (It’s Not AI)

If Viking Therapeutics Is Acquired, Here’s Who Wins

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

Three Biotechs That Are Top Takeover Targets

Barclays Hikes Eli Lilly Price Target to $1,400: Tirzepatide Momentum Steals the Show

Fast Money Panel Says Novo Nordisk Now More Compelling Than Eli Lilly After Falling 70%

JPMorgan Initiates Hims & Hers With Overweight: Could the Novo Nordisk Deal Be the Turning Point?

Biotech Investor Alex Karnal: GLP-1 Drugs Signal ‘Trillion-Dollar Revolution’ in Public Health

Hims & Hers Rallies 9% as Investors Bet Big on Peptide Pipeline and Novo Nordisk Deal

Live Nasdaq Composite: Markets Extend Rebound, Oil Slips in Pivot Toward Tech Deals

Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader

Live: Will Applied Materials Crush Tonight’s Q3 Earnings After 200% Rally?

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

The 3 Questions to Ask Before Opening a High-Yield Savings Account

Don’t Open a HYSA Until You’ve Done These 2 Things

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent's Share or Watch It Get Split Among the Aunts and Uncles

The 3 Questions to Ask Before Opening a High-Yield Savings Account

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

The 3 Questions to Ask Before Opening a High-Yield Savings Account

Novo Nordisk : NVO

All Novo Nordisk Articles

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Eli Lilly vs Novo Nordisk: The Battle for Obesity Drug Supremacy

The GLP-1 stock nobody is pricing in isn’t a drugmaker

Live Nasdaq Composite: Markets Take a Breather amid Stellar AI Earnings Cycle

5 Stocks Set to Cash in on The Next 90-Million Customer Industry. (It’s Not AI)

If Viking Therapeutics Is Acquired, Here’s Who Wins

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

Three Biotechs That Are Top Takeover Targets

Barclays Hikes Eli Lilly Price Target to $1,400: Tirzepatide Momentum Steals the Show

Fast Money Panel Says Novo Nordisk Now More Compelling Than Eli Lilly After Falling 70%

JPMorgan Initiates Hims & Hers With Overweight: Could the Novo Nordisk Deal Be the Turning Point?

Biotech Investor Alex Karnal: GLP-1 Drugs Signal ‘Trillion-Dollar Revolution’ in Public Health

Hims & Hers Rallies 9% as Investors Bet Big on Peptide Pipeline and Novo Nordisk Deal

Live Nasdaq Composite: Markets Extend Rebound, Oil Slips in Pivot Toward Tech Deals

Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader

Live: Will Applied Materials Crush Tonight’s Q3 Earnings After 200% Rally?

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

The 3 Questions to Ask Before Opening a High-Yield Savings Account

Don’t Open a HYSA Until You’ve Done These 2 Things

Featured Reads

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent's Share or Watch It Get Split Among the Aunts and Uncles

The 3 Questions to Ask Before Opening a High-Yield Savings Account